Company profilePharmaceutical#376 of 1,318 in Pakistan3 DRAP alerts

HAKIMSONS IMPEX (PVT) LTD.

Pharmaceutical company · 45 brands · 38 molecules

Ranked #5 of 12 companies in Immune Sera And Immunoglobulins

45 registered products 27 pharmaceutical brands 38 distinct molecules 3 DRAP alerts

Company overview

registered products

pharmaceutical brands

distinct molecules

therapeutic classes

DRAP alerts

HAKIMSONS IMPEX (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 45 product registrations across 38 distinct molecules. Its portfolio is concentrated in Immune Sera And Immunoglobulins and Vaccine. DRAP has issued 3 alerts involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by HAKIMSONS

13 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Immune Sera And Immunoglobulins 1

Rhophylac300mcgRs 6,054

Other 12

Celdach100mgceiling Rs 38,688.31 Celdach50mgceiling Rs 19,751.41 Celtere20mgceiling Rs 16,289.82 Celzar1000mgceiling Rs 16,961.77 Celzar200mgceiling Rs 3,410.68 Cosalon50mgceiling Rs 2,250.03 Human Albumin20% 50mlRs 17,456.25 Human Albumin20% 50mlRs 17,527.5 Human Albumin20% 100mlRs 35,055 Humanalbumin50mlRs 17,456.25 Humanalbumin100mlRs 35,055 Xelocel500mgceiling Rs 35,633.98

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

ceilings with an approval date

not revised in 2+ years

2026

oldest approval year

20268

Top molecules by brand count

Rho Immune Globulin3 brands

Oxaliplatin3 brands

Gemcitabine3 brands

Anti-D Immunoglobulin2 brands

Diphtheria Antitoxin2 brands

Docetaxel2 brands

Immune Globulin2 brands

Capecitabine2 brands

Caspofungin2 brands

Bicalutamide2 brands

Therapeutic classes

Conditions treated

Price band (DRAP official ceilings)

Registered products priced by source

DRAP-official25 products · Rs 90.04 – Rs 38,688.31

DVAGO3 products · Rs 17,456.25 – Rs 35,055

Servaid1 products · Rs 6,054 – Rs 6,054

Median across source: Rs 16,289.82

Regulatory record

3 alerts in the DRAP feed we track.

10. Rapid Alert – Spurious Injection RHOPHYLAC 300 µg (Batch # P100707423)

2026-03-11

Rapid Alert: PRESENCE OF FALSIFIED INJECTION RHOPHYLAC 300MCG, HUMAN ANTI-D IMMUNOGLOBULIN

2025-04-30

Rapid Alert: Falsified Rhophylac 300mcg PFS, Human Anti-D Immunoglobulin Injection Identif

2024-11-07

Competitive set

Companies whose registered portfolio overlaps most with this one.

SANOFI AVENTIS (PAKISTAN) LTD.10 shared molecules

SIND MEDICAL STORES10 shared molecules

HELIX PHARMA (PRIVATE) LIMITED9 shared molecules

Pharmasol (Pvt) Ltd.8 shared molecules

AMSON VACCINES & PHARMA (PVT) LTD.7 shared molecules

HI-WARBLE PHARMACEUTICAL (PVT) LTD7 shared molecules

Himmel Pharmaceuticals Private Limited DSL: 05-352-0065-016174D7 shared molecules

Atco Pharma International (Pvt) Ltd7 shared molecules

GlaxoSmithKline Pakistan Limited6 shared molecules

Himmel Pharmaceuticals Private Limited6 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

SANOFI AVENTIS (PAKISTAN) LTD. holds 74 molecules not in this portfolio

SIND MEDICAL STORES holds 5 molecules not in this portfolio

HELIX PHARMA (PRIVATE) LIMITED holds 110 molecules not in this portfolio

Get the full profile for HAKIMSONS

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included